NCT07078578

Brief Summary

This study aims to develop and prospectively validate a machine learning-based prediction model for postoperative delirium in kidney transplant recipients, using perioperative clinical data. Delirium is a common and serious postoperative complication that significantly increases morbidity, mortality, and healthcare costs. By analyzing electronic medical records from kidney transplant patients, including preoperative, intraoperative, and postoperative variables, the study seeks to identify high-risk patients and key predictors. Six machine learning models, including XGBoost, LGBM, GBC, LR, ANN, and SVM, will be constructed and evaluated, with a soft voting ensemble classifier used to optimize prediction performance. The goal is to improve early recognition and clinical management of postoperative delirium in kidney transplant patients.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2016

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
8.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 13, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 22, 2025

Completed
Last Updated

July 22, 2025

Status Verified

July 1, 2025

Enrollment Period

8.9 years

First QC Date

July 13, 2025

Last Update Submit

July 13, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of Postoperative Delirium Within 7 Days After Kidney Transplantation

    Postoperative delirium will be identified within 7 days of surgery through automated extraction and structured analysis of electronic medical record text fields, including progress notes, nursing records, and medication orders for sedatives or anxiolytics. Delirium will be categorized by onset time, severity, treatment, and recovery status.

    7 days after surgery

Study Arms (2)

Delirium Group

Kidney transplant recipients who developed postoperative delirium within 7 days after surgery, identified through EMR text mining and structured data extraction.

Non-Delirium Group

Kidney transplant recipients who did not develop postoperative delirium within 7 days after surgery.

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adolescent and adult patients (aged 16 years and older) who underwent kidney transplantation at a single tertiary medical center between January 1, 2016, and May 31, 2025. The study includes retrospective data (2016-2024) for model development and prospective data (2025) for external validation. All included patients were discharged alive and had complete perioperative clinical data available for analysis.

You may qualify if:

  • Patients who underwent kidney transplantation at \[Hospital Name, if needed\] between January 1, 2016, and May 31, 2025.
  • Age ≥ 18 years at the time of transplantation.
  • Discharged alive from the hospital after surgery.
  • Complete perioperative clinical data available, including preoperative evaluations, intraoperative records, and postoperative documentation

You may not qualify if:

  • Patients with documented pre-existing delirium or major neurocognitive disorder before surgery.
  • Simultaneous or multi-organ transplantation (e.g., kidney-pancreas).
  • Death within 7 days postoperatively.
  • Incomplete or missing key electronic medical records preventing outcome assessment.
  • Patients who withdrew consent for use of clinical data for research purposes (for prospective part).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 13, 2025

First Posted

July 22, 2025

Study Start

January 1, 2016

Primary Completion

December 1, 2024

Study Completion

February 1, 2025

Last Updated

July 22, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

The dataset includes sensitive clinical information from kidney transplant patients. IPD will not be shared due to patient privacy concerns and institutional data use restrictions.